Well, using gene editing "software" probably is, crispr might be replaced in the next decade once researchers start expanding the library for NgAgo . It's (edit:crispr's) specificity is fairly low compared to newer methods and has a lot more potential side effects than NgAgo because crispr's targeting is more generic. That sorta sounded like a tautology, but it's not. One is how "choosy" it is when actually editing, the other is how choosy it is when "deciding" what to edit.
Edited for minor clarity.